LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Cardiff Oncology Appoints Mani Mohindru As Interim CEO 1/27/2026 7:12:02 AM
  • CytomX Therapeutics Outlines 2026 Milestones: Varseta-M CRC Trials Advancing, CX-801 Data Expected 1/8/2026 8:59:05 AM
  • Wedbush Is Raising CytomX Therapeutics, Inc. (CTMX) FY 25 Rev. Estimate To 79.5 M From 77.6 M 11/7/2025 10:35:08 PM
  • Wedbush Is Lowering CytomX Therapeutics, Inc. (CTMX) FY 26 Estimate To -0.52 From -0.49 11/7/2025 10:34:43 PM
  • Wedbush Is Lowering CytomX Therapeutics, Inc. (CTMX) Q4 26 Estimate To -0.14 From -0.13 11/7/2025 10:34:33 PM
  • Wedbush Is Cutting CytomX Therapeutics, Inc. (CTMX) Q3 26 Estimate To -0.14 From -0.13 11/7/2025 10:34:28 PM
  • Wedbush Is Lowering CytomX Therapeutics, Inc. (CTMX) Q2 26 Estimate To -0.14 From -0.13 11/7/2025 10:34:19 PM
  • Wedbush Is Lowering CytomX Therapeutics, Inc. (CTMX) Q1 26 Estimate To -0.11 From -0.10 11/7/2025 10:34:08 PM
  • Wedbush Is Lowering CytomX Therapeutics, Inc. (CTMX) FY 25 Estimate To -0.06 From -0.05 11/7/2025 10:33:55 PM
  • Wedbush Is Lowering CytomX Therapeutics, Inc. (CTMX) Q4 25 Estimate To -0.10 From -0.09 11/7/2025 10:33:43 PM
  • Wedbush Reiterates CytomX Therapeutics, Inc. (CTMX) At Outperform With $6 Price Target 11/7/2025 10:33:16 PM
  • CytomX Therapeutics Appoints Rachael Lester As Chief Business Officer 10/20/2025 4:07:25 PM
  • Wedbush Is Lowering CytomX Therapeutics, Inc. (CTMX) FY25 Rev. Estimate To 62.9 M From 114.3 M 5/12/2025 5:44:31 PM
  • Wedbush Is Lowering CytomX Therapeutics, Inc. (CTMX) Q3 25 Rev. Estimate To 4.0 M From 38.1 M 5/12/2025 5:44:21 PM